throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`______________
`
`APPLE INC.,
`Petitioner,
`
`v.
`
`OMNI MEDSCI, INC.,
`Patent Owner.
`
`______________
`
`
`U.S. Patent No. 9,651,533
`
`Case No.: IPR2019-00916
`
`______________
`
`
`
`
`
`PATENT OWNER’S SUR-REPLY TO PETITION
`FOR INTER PARTES REVIEW UNDER 37 C.F.R. § 42.220
`
`
`
`
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`TABLE OF CONTENTS
`
`Table of Authorities ............................................................................................... ii
`
`A.
`B.
`
`C.
`
`D.
`
`E.
`
`F.
`G.
`
`Introduction ....................................................................................... 1
`Apple rewrites the “pulse rate” limitation to remove the
`“configured to increase SNR” requirement ........................................ 3
`Apple mischaracterizes the deposition testimony of Omni
`MedSci’s expert ................................................................................. 7
`Lisogurski does not disclose a light source configured to
`increase SNR by increasing a pulse rate as claimed ..........................10
`Carlson’s teaching does not fill Lisogurski’s gap ..............................11
`1.
`Carlson teaches the solution to SNR issues is temporary
`modulation of an unmodulated light source at a
`predetermined rate ..................................................................11
`Carlson adds nothing to what Lisogurski teaches, so the
`combination cannot render the challenged claims obvious ......16
`Omni MedSci’s so-called “procedural arguments” are valid .............18
`Conclusion ...................................................................................... 211
`
`2.
`
`Certificate of Service ............................................................................................22
`
`Certificate of Compliance Pursuant to 37 C.F.R. § 42.24 ......................................23
`
`
`
`
`
`
`
`i
`
`

`

`Atty. Dkt. No.: OMSC0110IPR2
`
`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`
`
`Table of Authorities
`
`Cases
`
`Aspex Eyewear, Inc. v. Marchon Eyewear, Inc.,
`
`672 F.3d 1335 (Fed. Cir. 2012) ................................................................. 5, 6
`
`Centripetal Networks, Inc. v. Cisco Sys., Inc.,
`
`No. 2:18-CV-94, 2020 WL 863976 (E.D. Va. Feb. 20, 2020) ...................... 6
`
`Cook Grp. Inc. v. Boston Sci. Scimed, Inc.,
`
`IPR2017-00132, Paper No. 71 (PTAB Nov. 14, 2018) ................................. 5
`
`Hulu, LLC v. Sound View Innovations, LLC, IPR2018-00582,
`
`Paper No. 34 (PTAB Aug. 5, 2019) (Informative) .......................... 14, 15, 19
`
`In re Gordon,
`
`733 F.2d 900 (Fed. Cir. 1984) .....................................................................17
`
`Intelligent Bio-Sys., Inc. v. Illumina Cambridge Ltd.,
`
`821 F.3d 1359 (Fed. Cir. 2016) ...................................................................19
`
`Perdiem Co, LLC v. IndusTrack LLC, No. 2:15-CV-727-JRG-RSP,
`
`2016 WL 3633627 (E.D. Tex. July 7, 2016) ................................................ 6
`
`Phillips v. AWH Corp.,
`
`415 F.3d 1303 (Fed. Cir. 2005) .................................................................... 5
`
`Ruiz v. A.B. Chance Co.,
`
`357 F.3d 1270 (Fed. Cir. 2004) ...................................................................18
`
`SAS Institute Inc. v. Iancu,
`
`138 S.Ct. 1348 (2018) .................................................................................19
`
`SIPCO, LLC v. Amazon.com, Inc., No. 2:08-CV-359-JRG,
`
`2012 WL 5195942 (E.D. Tex. Oct. 19, 2012) .............................................. 6
`
`
`
`ii
`
`

`

`Atty. Dkt. No.: OMSC0110IPR2
`
`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`SwimWays Corp. v. Zuru, LLC, No. 2:13CV334,
`
`2014 WL 934447 (E.D. Va. Mar. 10, 2014) ................................................. 6
`
`TQ Delta, LLC v. Cisco Sys., Inc.,
`
`942 F.3d 1352 (Fed. Cir. 2019) ...................................................................17
`
`Typhoon Touch Techs., Inc. v. Dell, Inc.,
`
`659 F.3d 1376 (Fed. Cir. 2011) .................................................................... 5
`
`
`
`Statutes
`
`35 U.S.C. § 112 ....................................................................................................14
`35 U.S.C. § 312 .............................................................................................. 14, 19
`35 U.S.C. § 316 ....................................................................................................15
`
`
`
`Other Authorities
`
`Consolidated Trial Practice Guide (Nov. 2019).....................................................14
`
`
`
`
`
`
`iii
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`A.
`
`Introduction
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`Apple’s Reply rewrites the challenged claims, mischaracterizes the testimony
`
`of Omni MedSci’s expert, misconstrues the teachings of Lisogurski and Carlson, and
`
`improperly relies on obviousness arguments Apple did not make in its Petition.
`
`Separately and combined, Lisogurski and Carlson fail to disclose or render obvious
`
`“a light source configured to increase signal-to-noise ratio [“SNR”] . . . by
`
`increasing a pulse rate of at least one of the plurality of semiconductor sources.”
`
`(Ex. 1001 29:51-11.)1, 2
`
`In its Institution Decision (“ID”), the Board correctly determined that
`
`Lisogurski’s system varies an LED’s pulse rate but not to increase SNR. (Paper
`
`No. 16, ID at 31.) Apple’s response is, if a pulse rate increases, SNR may (or may
`
`not) increase and that hit-or-miss result is “configured to increase signal-to-noise
`
`ratio.” It is not.
`
`Lisogurski discloses two forms of light source modulation, neither of which
`
`is configured to increase SNR by increasing a pulse rate as claimed. First,
`
`Lisogurski discloses “cardiac cycle modulation” which is “aligned with pulses of the
`
`
`1 Throughout this Sur-reply, all emphasis added unless otherwise noted.
`
`2 Omni MedSci’s focus on the “pulse rate” limitation is not an admission that the
`
`references disclose the other limitations of the challenged claims.
`
`1
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`heart” or “other suitable physiological cyclical cycle.” (Ex. 1011 at 5:25-47.) This
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`cardiac cycle modulation is “on the order of 1 Hz” correlating with an average heart
`
`rate of 60 beats per minute. (Id. at 6:28-29.) This is shown, for example, by blocks
`
`532 and 534 in Fig. 5, which illustrate a red LED turning on and off in
`
`synchronization with the cardiac cycle (“PPG”). (Id. at 21:45-53.) Lisogurski
`
`explains that the “firing rate” of this cardiac cycle modulation can be adjusted to
`
`track the cardiac cycle. (Id. at 25:45-58; 28:30-39; 29:25-34.) But as the Board
`
`already determined, Lisogurski’s light source is not configured to increase SNR by
`
`increasing the pulse rate as claimed. (Paper No. 16, ID at 31.)
`
`Second, Lisogurski also describes “a technique to remove ambient and
`
`background signals” by measuring ambient light while the LED is off and
`
`subtracting that measurement from the signals received with the light on. (Id. at 6:7-
`
`30.) Lisogurski says this can be done at an exemplary modulation rate of “1 kHz”
`
`using separate “drive cycle modulation.” (Ex. 1011 at 5:48-54; 6:30.) Apple ignores
`
`this section of Lisogurski and does not rely on it to show obviousness of the “pulse
`
`rate” limitation. Lisogurski does not disclose varying the frequency of the drive
`
`cycle modulation and does not disclose or render obvious increasing the pulse rate
`
`to increase SNR as claimed.
`
`Apple adds Carlson purportedly to provide what is missing from Lisogurski.
`
`But Carlson adds nothing relevant to Lisogurski because the two references contain
`
`2
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`identically the same teaching—right down to the same exemplary 1000 Hz
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`modulation rate. (Compare Ex. 1011, Lisogurski, at 6:30 with Ex. 1009, Carlson, at
`
`[0069].) In fact, Carlson adds less than nothing because it merely modulates an
`
`unmodulated
`
`light source
`
`temporarily without varying
`
`the predetermined
`
`modulation frequency. An ordinary artisan reading Carlson would learn nothing
`
`new beyond what Lisogurski already discloses, which the Board correctly
`
`determined is not the claimed configuration. (Paper No. 16, ID at 30.)
`
`Alone or combined, the references fail to disclose or render obvious “a light
`
`source configured to increase signal-to-noise ratio . . . by increasing a pulse rate of
`
`at least one of the plurality of semiconductor sources.” The Board should confirm
`
`the patentability of the challenged claims.
`
`B. Apple rewrites the “pulse rate” limitation to remove the
`“configured to increase SNR” requirement
`
`Apple argues that its references satisfy the claims merely because, if the pulse
`
`rate of the light source increases, the SNR may increase, too. (Reply at 1, 3-4.) To
`
`make that argument, Apple rewrites the “pulse rate” limitation. Apple wrongly
`
`asserts:
`
`there is: (i) an action that the device must take (increasing the pulse rate
`
`of an LED) and (ii) a result of that action (an increased SNR).
`
`(Reply at 6-7.)
`
`3
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`Apple’s summary of the “pulse rate” limitation is wrong because it is
`
`backward. The claim requires a light source “configured to increase SNR,” not a
`
`light source “configured to increase a pulse rate.” So, when Apple says, “Lisogurski
`
`teaches a device that is ‘configured to’ take the action specified by the claim:
`
`increasing the pulse rate of an LED” (Reply at 7), Apple distorts the claim. Apple
`
`has set up a strawman. It is irrelevant that Lisogurski discloses a device that varies
`
`a pulse rate because that is not the claimed configuration. As Apple aptly
`
`summarized, “[t]he Board preliminarily found that Lisogurski alone does not
`
`disclose increasing pulse rate for the purpose of increasing SNR.” (Reply at 7, n.
`
`2, citing ID at 30.)3 Apple has not shown Lisogurski and Carlson—separately or
`
`together—are “configured to increase SNR” by “increasing a pulse rate.”
`
`
`3 The Board found, and Apple does not dispute, that Lisogurski’s “LED firing rate
`
`is varied to become or remain synchronous with a cardiac cycle, not to increase
`
`signal-to-noise.” (Paper No. 16, ID at 30.) The Board also found, and Apple does
`
`not dispute, that “Lisogurski is teaching varying the sampling rate to be synchronous
`
`with the cardiac cycle, not to improve signal-to-noise.” (Id. at 31.)
`
`4
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`Apple also asserts that Omni MedSci’s “configured to” construction injects
`
`an improper “intent” requirement. (Reply at 6-8.)4 But Omni MedSci’s construction
`
`is not based on “intent,” it is based on the express claim language: a “light source
`
`configured to increase signal-to-noise ratio . . . .” (Ex. 1001 29:51-11.) This express
`
`claim language is always relevant to the proper construction. Phillips v. AWH Corp.,
`
`415 F.3d 1303, 1313 (Fed. Cir. 2005).
`
`Apple does not rebut Omni MedSci’s arguments or defend the Board’s
`
`substitution of “capable of” for the claims’ “configured to.” In its Response (pp. 10-
`
`11), Omni MedSci cited and discussed Aspex Eyewear, Inc. v. Marchon Eyewear,
`
`Inc., 672 F.3d 1335, 1349 (Fed. Cir. 2012) (“configured to” has a narrower meaning
`
`than “capable of”) and Cook Grp. Inc. v. Boston Sci. Scimed, Inc., IPR2017-00132,
`
`Paper No. 71 at 17 (PTAB Nov. 14, 2018) (“the claim language ‘configured to’
`
`requires structure designed to perform the function, not merely structure capable of
`
`
`4 Apple also addresses, briefly, Omni MedSci’s criticism that the Board’s
`
`construction improperly broadens the “pulse rate” limitation to permit, e.g., a human,
`
`and not the “light source,” to increase the pulse rate. (Reply at 6.) Apple asserts the
`
`Board’s construction is “irrelevant,” but does not defend it or rebut Omni MedSci’s
`
`arguments. (Id.)
`
`5
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`performing the function.”).5 Aspex Eyeware is controlling Federal Circuit law.
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`Apple does not address either decision in its Reply.
`
`
`5 See also Typhoon Touch Techs., Inc. v. Dell, Inc., 659 F.3d 1376, 1380 (Fed. Cir.
`
`2011) (distinguishing between a device configured to perform a certain function and
`
`a device that is simply capable of being configured to perform that function);
`
`Centripetal Networks, Inc. v. Cisco Sys., Inc., No. 2:18-CV-94, 2020 WL 863976, at
`
`*7 (E.D. Va. Feb. 20, 2020) (“plain and ordinary meaning” of “configured to”
`
`“requires that the device be actually configured to do the function”); Perdiem Co,
`
`LLC v. IndusTrack LLC, No. 2:15-CV-727-JRG-RSP, 2016 WL 3633627, at *41
`
`(E.D. Tex. July 7, 2016) (“[N]one of the general-usage dictionaries consulted by the
`
`Court defines ‘configure’ as to render merely ‘capable of.’”); SwimWays Corp. v.
`
`Zuru, LLC, No. 2:13CV334, 2014 WL 934447, at *11 (E.D. Va. Mar. 10, 2014) (“a
`
`construction that an appendage is merely ‘capable’ of propelling a figure through a
`
`liquid fails to adequately convey that the appendage is actually ‘configured to’
`
`propel the figure through the liquid.”); SIPCO, LLC v. Amazon.com, Inc., No. 2:08-
`
`CV-359-JRG, 2012 WL 5195942, at *55 (E.D. Tex. Oct. 19, 2012) (citing the
`
`“Internet version of The American Heritage Dictionary defining ‘configured’ as
`
`‘designed, arranged, set up, or shaped with a view to specific applications’”).
`
`6
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`Omni MedSci also pointed out that other limitations of the ’533 Patent claims
`
`use the term “capable of,” triggering the presumption that the term “configured to”
`
`recited in independent claims 5 and 13 has a different, i.e., narrower, meaning than
`
`“capable of.” Aspex, 672 F.3d at 1349. Again, Apple ignores this argument and
`
`does not dispute it.
`
`Substituting “capable of” for “configured to” would render the “pulse rate”
`
`limitation meaningless and irrelevant. But the ‘533 Patent does not claim mere
`
`happenstance. The device must be “configured to”—i.e., designed to—increase
`
`SNR in the manner claimed.
`
`C. Apple mischaracterizes the deposition testimony of Omni
`MedSci’s expert
`
`On page 1, Apple’s attorneys assert, “increase the pulse rate of an LED and
`
`that increase will necessarily increase SNR as well.” Apple cites no evidence to
`
`support that assertion and no evidence exists. But Apple’s obviousness argument
`
`hinges on Apple proving that increasing a pulse rate necessarily increases SNR
`
`because the claims require a light source “configured to” increase SNR.
`
`Apple selectively quotes Omni MedSci’s expert, Dr. MacFarlane, but he
`
`repeatedly disagreed when Apple suggested increasing a pulse rate would
`
`necessarily increase SNR. (Ex. 1060 at 37:17-22; 38:4-7; 38:19-39:1; 39:12-17;
`
`82:8-83:4.) Dr. MacFarlane acknowledged, in general, that increasing a pulse rate
`
`7
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`may increase SNR, but he consistently refuted Apple’s suggestion that it necessarily
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`does so. Apple emphasizes Dr. MacFarlane’s answer to a contradictory question but
`
`omits his explanation about why the question was contradictory. (Reply at 4-5.)
`
`Omni MedSci reproduces the original question and answer together with Dr.
`
`MacFarlane’s explanation of why the question was contradictory:
`
`Q. [by Apple] Will you agree that in general, when you increase the
`
`pulse rate of an LED, you will increase the signal-to-noise ratio, though
`
`that won’t always happen?
`
`THE WITNESS: Yes.
`
`* * *
`
`THE WITNESS: [on redirect] . . . The -- the question was -- was -- was
`
`poorly phrased, in my opinion. I mis- -- I misunderstood it. The
`
`beginning of it was "in general"; the end of it was "not always," making
`
`the question contradictory -- those two pieces are contradictory, and so
`
`I answered erroneously. I'd like to change my answer from a yes to a
`
`no.
`
`(Ex. 1060, 37:12-17; 81:4-18).
`
`On re-cross, Dr. MacFarlane elaborated further in response to Apple’s
`
`questions:
`
`Q. [by Apple] . . . Dr. MacFarlane, when you increase a pulse rate of an
`
`LED, in some circumstances, you'll increase the signal-to-noise ratio;
`
`is that correct?
`
`8
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`THE WITNESS: Increasing the -- increasing the frequency can
`
`sometimes increase the signal-to-noise ratio.
`
`Q. In general, does increasing the pulse rate of an LED increase the
`
`signal-to-noise ratio?
`
`THE WITNESS: I can't -- I can't say that in general.
`
`Q. Why not?
`
`A. There may be instances where that doesn't happen.
`
`* * *
`
`Q. Do you agree that if you increase the pulse rate of an LED, typically,
`
`the signal-to-noise ratio will increase?
`
`THE WITNESS: I neither agree nor disagree with that.
`
`Q. Do you agree that if you increase the pulse rate of an LED,
`
`sometimes the signal-to-noise ratio will increase?
`
`THE WITNESS: Sometimes increasing the modulation or the pulse rate
`
`of a -- of a -- of an LED can increase the signal-to-noise ratio of -- of
`
`the measurement.
`
`(Id. at 82:8-85:7, objections to form omitted.) None of this testimony supports
`
`Apple’s claim that “increase the pulse rate of an LED and that increase will
`
`necessarily increase SNR as well.” (Reply at 1.)
`
`Apple also asserts that Dr. MacFarlane could not name a scenario in which
`
`SNR would not increase with an increase in pulse rate. (Reply at 5.) Not true. In
`
`response to Apple’s request for “an example of when increasing the pulse rate of an
`
`9
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`LED does not increase the [SNR],” Dr. MacFarlane gave Apple a specific example.
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`(Id. at 83:19-84:13.) Apple’s Reply ignores, and does not rebut, the example Dr.
`
`MacFarlane provided, and Apple did not ask Dr. MacFarlane to give other examples,
`
`which he could have done.
`
`Dr. MacFarlane’s testimony—that increasing pulse rate may or may not
`
`increase SNR—highlights the fallacy of Apple’s argument. The claims do not say
`
`“perhaps increase SNR”—the light source must be “configured to increase [SNR].”
`
`Lisogurski, alone or combined with Carlson, does not meet that requirement
`
`because, at best, they teach a varying pulse rate that is not “configured to” increase
`
`SNR.
`
`D. Lisogurski does not disclose a light source configured to increase
`SNR by increasing a pulse rate as claimed
`
`The Board correctly determined that the system described in Lisogurski is
`
`configured to vary a pulse rate to track a person’s cardiac cycle, not to increase SNR
`
`by increasing a pulse rate as claimed. (Paper No. 16, ID at 30-31.) Apple confirms
`
`that Lisogurski ties the LED pulse rate to the person’s cardiac cycle:
`
`Lisogurski describes applying cardiac cycle modulation to the pulsing
`
`of its LEDs, which means that its device will increase the sampling rate
`
`and emitter firing rate to become or remain synchronous with a cardiac
`
`cycle. Ex.1011, 25:49-55; 31:11-24, 31:39-55; see Inst. Dec., 30. When
`
`Lisogurski’s device applies that modulation technique, depending on
`
`10
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`the individual’s cardiac cycle, the device will increase its LED pulse
`
`rate. Ex.1003, ¶ 96 (“Cardiac cycle modulation schemes would adjust
`
`the brightness of a light in a way that is synchronized to the cardiac
`
`cycle and similar to or faster than the cardiac pulse rate.”).
`
`(Reply at 10.) And, while this may all be true, merely increasing a pulse rate is not
`
`what the ‘533 Patent claims require.
`
`Apple also asserts Lisogurski discloses “increasing the sampling rate” to
`
`increase accuracy. (Reply at 11.) But the challenged claims do not recite increasing
`
`a “sampling rate” (i.e., the detection rate), they recite increasing a “pulse rate” of the
`
`light source. As the Board explained, “when Lisogurski teaches ‘varying light
`
`output may also apply to sampling rate,’ Lisogurski is teaching varying the sampling
`
`rate to be synchronous with the cardiac cycle, not to improve signal-to-noise.”
`
`(Paper No. 16, ID at 31 citing Ex. 1011 at 35:5–9.) Thus, Lisogurski, alone, does
`
`not disclose the “pulse rate” limitation.
`
`E. Carlson’s teaching does not fill Lisogurski’s gap
`
`1.
`
`Carlson teaches the solution to SNR issues is temporary
`modulation of an unmodulated light source at a
`predetermined rate
`
`Carlson teaches a pulsoximeter sensor whose “basic idea” is to “use a beam-
`
`shaping element . . . to direct the emitted optical radiation” of a “light source” to
`
`“increase the optical signal power . . . and thus increasing the Signal/Noise-and
`
`signal/Background ratio.” (Ex. 1009 at [0014].) This “basic idea” does not have a
`
`11
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`modulated light source, which Carlson introduces later in the specification. (Id. at
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`[0018].)
`
`In later embodiments, Carlson proposes “temporarily” modulating the
`
`otherwise unmodulated light source:
`
`• “temporarily modulate the amplitude of the optical radiation”;
`
`• “it is further proposed to temporarily modulate the amplitude of the
`
`optical radiation of the light source”;
`
`• “[t]he basic idea of using AC-Coupling or Lock-In Amplification
`
`detection means is to temporarily modulate the optical radiation”;
`
`• “it is furthermore possible to use a light source modulation to
`
`temporarily modulate the optical radiation of the LED”;
`
`• “temporarily modulate the optical radiation of the LED at the carrier
`
`frequency fc in order to shift the power spectrum.”
`
`(Ex. 1009 at [0020], [0027], [0064], [0065].)
`
`An ordinary artisan would understand that Carlson’s solution to an SNR
`
`problem is to temporarily modulate the otherwise unmodulated light source at a
`
`predetermined frequency. Apple agrees this is Carlson’s teaching:
`
`To handle interference from ambient light when present, Carlson
`
`explains that its device “temporarily modulate[s] the amplitude of the
`
`optical radiation of, e.g., the LED at a carrier frequency fc in order to
`
`12
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`shift the power spectrum of the pulsoximeter signals into a higher
`
`frequency range where environmental optical radiation is unlikely.”
`
`(Reply at 14.)6
`
`Apple’s attorneys assert, without evidence, this disclosure in Carlson
`
`“indicat[es] that the LED previously emitted pulses at a lower frequency—i.e., that
`
`Carlson is switching between at least two different frequencies.” (Reply at 14, citing
`
`Carlson at [0020].) But Carlson only discloses temporary modulation, not, as
`
`Apple’s attorneys assert, modulation at different (or increasing) rates as claimed.
`
`Carlson’s “temporarily modulate” disclosures confirm that the change described in
`
`Carlson is from an unmodulated light source to a temporarily modulated light source
`
`at a chosen, unvarying pulse rate—not a pulsing light source configured to increase
`
`SNR by increasing its pulse rate as claimed.7
`
`
`6 As explained by Dr. MacFarlane, shifting a “power spectrum” is different from
`
`increasing a pulse rate. (Ex. 2122, MacFarlane Decl., ¶ 83.)
`
`7 Apple’s attorneys also assert Omni’s reading of Carlson “would consume excessive
`
`battery power.” (Reply at 15.) They never explain their new assertion and it is
`
`incorrect. Carlson’s first two embodiments disclose “at least one light source which
`
`can emit light at least at two wavelengths.” (Ex. 1009 at [0012] and [0016].) And
`
`Fig. 7c is “a diagram showing power spectrum of physiological signals and ambient
`
`13
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`Apple points to dependent claims 10-13 of Carlson reciting a “means” that
`
`can “shift the frequency of the emitted light.” (Reply at 15.) Apple never made this
`
`argument in its Petition,8 and it is incorrect. The claimed “means” must be construed
`
`to cover the specific structures and materials disclosed in the specification for
`
`performing the claimed function and equivalents. See 35 U.S.C. § 112(f). The only
`
`frequency shifting Carlson teaches is the introduction of a carrier frequency to shift
`
`the frequency of the “power spectrum” of the unmodulated light—not increasing the
`
`
`light without . . . modulation of the light source of a sensor.” (Id. at [0044].)
`
`Carlson follows these two embodiments with several “alternative” configurations in
`
`which the light source is “temporarily modulate[d].” (Ex. 1009 at [0018-20] and
`
`[0027].) Carlson thus discloses unmodulated light (i.e., not the “temporarily
`
`modulated” light) in the first two embodiments. This refutes Apple’s new—and
`
`unsupported—“battery power” argument.
`
`8 It is improper for Apple to introduce new arguments in its Reply that it did not
`
`make in its Petition. See 35 U.S.C. § 312(a)(3); Consolidated Trial Practice Guide
`
`(Nov. 2019) at 73 (“Petitioner may not submit new evidence or argument in reply
`
`that it could have presented earlier, e.g. to make out a prima facie case of
`
`unpatentability.”); Hulu, LLC v. Sound View Innovations, LLC, IPR2018-00582,
`
`Paper No. 34 at 30-31 (PTAB Aug. 5, 2019) (Informative).
`
`14
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`“pulse rate” as claimed. (Ex. 1009 at [0020] and [0027].) As explained by Dr.
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`MacFarlane, the claimed pulse rate and Carlson’s power spectrum are different
`
`concepts. (Ex. 2122, MacFarlane Decl., ¶ 83.)
`
`Finally, Apple argues that switching among different frequencies is “common
`
`sense.” (Reply at 15-16.) Because Apple presented no “common sense” argument
`
`in its Petition, and because Apple’s expert does not support the new “common sense”
`
`theory, the Board should not give any weight to Apple’s new “common sense”
`
`argument. Hulu, IPR2018-00582, Paper No. 34 at 30-31. In addition, Carlson
`
`proceeds contrary to Apple’s purported “common sense.” Carlson uses an approach
`
`in which a modulation frequency “is chosen in such a way that it is outside the
`
`frequency spectrum of sunlight and of ambient light which, according to FIG. 7b, is
`
`in the range of above approximately 1000 Hz.” (Ex. 1009, Carlson at [0069].)
`
`Carlson thus solves the varying interference problem by choosing a single frequency
`
`above all expected interference, i.e., above approximately 1000 Hz. (Id.) Relying
`
`on mere attorney argument, Apple supplies no evidence an ordinary skilled artisan
`
`would have rejected these teachings of Carlson. Apple’s lack of evidence means
`
`that Apple has not met its burden of proof. 35 U.S.C. § 316(e).
`
`15
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`2.
`
`Carlson adds nothing to what Lisogurski teaches, so the
`combination cannot render the challenged claims obvious
`
`Apple relies on its misinterpretation of Carlson to assert, incorrectly, “The
`
`salient point is that Carlson teaches that when ambient light is present, SNR can be
`
`increased by increasing a pulse rate of an LED to a frequency range that mitigates
`
`ambient noise,” i.e., “in the range of above approximately 1000 Hz.” (Reply at 19-
`
`20.) Apple is wrong for two reasons.
`
`First, Carlson has no teaching of “increasing a pulse rate” for the reasons
`
`discussed in the preceding subsection. Second, using “a frequency range [such as
`
`1000 Hz] that mitigates ambient noise” is not new information.
`
`Lisogurski teaches a way “to remove ambient and background signals” by
`
`measuring ambient light while the LED is off and subtracting it from the signals
`
`received with the light on. (Id. at 6:7-19.) Lisogurski says off/on measurement can
`
`be done at an exemplary modulation rate of 1000 Hz (“1 kHz.”) (Id. at 6:30.)
`
`Specifically, Lisogurski discloses:
`
`
`
`In some embodiments, a technique to remove ambient and
`
`background signals may be used in addition to or in place of a power
`
`saving light modulation scheme. In a drive cycle modulation technique,
`
`the system may cycle light output at a rate significantly greater than the
`
`cardiac cycle. For example, a drive cycle modulation cycle may include
`
`the system turning on a first light source, followed by a “dark” period,
`
`followed by a second light source, followed by a “dark” period. The
`
`16
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`system may measure the ambient light detected by the detector during
`
`the “dark” period and then subtract this ambient contribution from the
`
`signals received during the first and second “on” periods. . . . The
`
`cardiac cycle modulation may represent a lower frequency envelope
`
`function on the higher frequency drive cycle. For example, cardiac
`
`cycle modulation may be an envelope on the order of 1 Hz
`
`superimposed on a 1 kHz sine wave drive cycle modulation.
`
`(Id., 6:7-30.)9
`
`Thus, as relevant here, Carlson teaches nothing that Lisogurski does not
`
`already know, namely ambient/background signals can be a problem and 1000 Hz is
`
`a useful frequency. Lisogurski solved his noise problem using off/on subtraction
`
`at 1000 Hz. Carlson solved his noise problem by temporarily modulating the LED
`
`above 1000 Hz. But the references do not teach or even suggest increasing the
`
`exemplary the 1000 Hz rate for any reason, let alone for the purpose of increasing
`
`SNR as the claims require. The record is devoid of any evidence that would render
`
`the claimed “pulse rate” limitation obvious.
`
`Moreover, no motivation exists to configure a light source to increase SNR
`
`by increasing a pulse rate. “The mere fact that the prior art could be so modified
`
`
`9 Apple ignores this portion of Lisogurski and does not rely on it to show obviousness
`
`of the “pulse rate” limitation.
`
`17
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`would not have made the modification obvious unless the prior art suggested the
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`desirability of the modification.” In re Gordon, 733 F.2d 900, 902 (Fed. Cir. 1984).
`
`Apple identifies no proper motivation. Instead, using the ‘533 Patent as a roadmap,
`
`Apple improperly conjures motivation using hindsight reasoning. See TQ Delta,
`
`LLC v. Cisco Sys., Inc., 942 F.3d 1352, 1361 (Fed. Cir. 2019) (discussing the “risks
`
`[of] allowing the challenger to use the challenged patent as a roadmap to reconstruct
`
`the claimed invention using disparate elements from the prior art—i.e., the
`
`impermissible ex post reasoning and hindsight bias that KSR warned against.”); Ruiz
`
`v. A.B. Chance Co., 357 F.3d 1270, 1275 (Fed. Cir. 2004) (“This form of hindsight
`
`reasoning, using the invention as a roadmap to find its prior art components, would
`
`discount the value of combining various existing features or principles in a new way
`
`to achieve a new result—often the very definition of invention.”) Apple has failed
`
`to make a prima facie case of obviousness.
`
`F. Omni MedSci’s so-called “procedural arguments” are valid
`
`Apple attacks what it calls Omni MedSci’s “unfounded procedural
`
`arguments.” (Reply at 22.) Apple first asserts that Omni MedSci argued that Apple
`
`was trying to “bodily incorporat[e]” a “feature of Carlson into Lisogurski’s device.”
`
`(Id.) On the contrary, Omni MedSci did not assert Apple was trying to bodily
`
`incorporate one reference into another. Neither reference teaches nor renders
`
`18
`
`

`

`Case No.: IPR2019-00916
`Patent No.: 9,651,533
`
`
`obvious the claimed “pulse rate” limitation because they are not configured to
`
`Atty. Dkt. No.: OMSC0110IPR2
`
`increase SNR by increasing a pulse rate.
`
`Next, Apple contends Omni MedSci was wrong about Apple’s prima facie
`
`obviousness case, focusing on Omni MedSci’s purported argument that “neither
`
`Carlson nor Lisogurski alone” render the claims obvious. (Reply at 23.) Omni
`
`MedSci did not merely assert that the references “alone” fail to disclose the “pulse
`
`rate” limitation. Omni MedSci’s Response went beyond that statement, as does this
`
`Sur-reply, detailing why the references in comb

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket